Results 161 to 170 of about 191,461 (236)

How to report neurotechnology and artificial intelligence studies in epilepsy: Peer‐review‐inspired recommendations

Epilepsia Open, EarlyView.
Abstract Objective The integration of neurotechnology and artificial intelligence (AI) in epilepsy research has led to significant advancements in diagnosis, monitoring, and treatment. However, the impact of these innovations is often diminished by inadequate and inaccurate reporting, limiting their reproducibility and implementation.
Pedro F. Viana, Matthew McWilliam, Andrea Biondi, Jesus Servando Medel‐Matus, Naoto Kuroda, Giulia Sofia Cereda, Aristea S. Galanopoulou   +6 more
wiley   +1 more source

Sudden unexpected death in epilepsy (SUDEP): Risk management of pediatric patients with epilepsy

Epilepsia Open, EarlyView.
Abstract Objective Sudden unexpected death in epilepsy (SUDEP) is the leading cause of death in people with epilepsy with an incidence of 1:1000. The primary risk factors for SUDEP are generalized or focal to bilateral tonic–clonic seizures. Preventive measures like nighttime monitoring devices and resuscitation training address modifiable risk factors.
Laura Lutz, Lena Luise Becker, Alwina Koch, Angela M. Kaindl   +3 more
wiley   +1 more source

Neonatal seizures and GABAergic drugs: Scylla and Charybdis?

Epilepsia Open, EarlyView.
Abstract Neonates have a high incidence of seizures that are frequently difficult to control with conventional first‐line anti‐seizure medications, which are gamma‐aminobutyric acid (GABA) agonists. The reasons for this clinical problem are multifold but are likely related to the unique physiology of the immature nervous system. Specifically, the early
Kerry W. Thompson, Lucie Suchomelova, Claude G. Wasterlain   +2 more
wiley   +1 more source

Editorial: Neuroimaging in psychiatry 2023: schizophrenia

Frontiers in Psychiatry
Massimo Tusconi, Serdar M. Dursun
doaj   +1 more source

Preparing for the implementation of anti-amyloid therapies in Europe: Assessing real-world eligibility for lecanemab and donanemab in a Swedish memory clinic. [PDF]

J Prev Alzheimers Dis
Rosenberg A, Solomon A, Bonnard A, Daniilidou M, Hagman G, Hall A, Matton A, Öhlund-Wistbacka U, Westman E, Kivipelto M.   +9 more
europepmc   +1 more source

Characterizing electroencephalogram dynamics during sedation withdrawal: Insights into cortical recovery following status epilepticus

Epilepsia Open, EarlyView.
Abstract Objective Characterize electroencephalogram (EEG) dynamics during propofol withdrawal in patients with generalized convulsive status epilepticus (GCSE) and explore their association with functional outcomes. Methods We conducted a retrospective cohort study of adult patients with GCSE who received continuous EEG monitoring and propofol ...
Mathieu Dhoisne, Philippe Derambure, Arnaud Delval, Saad Nseir, Nacim Betrouni, Romain Tortuyaux   +5 more
wiley   +1 more source

Clinical Outcomes After Temperament Based Therapy With Support (TBT‐S): A 12‐Month Naturalistic Follow‐Up Study

European Eating Disorders Review, EarlyView.
ABSTRACT Objective This study investigated clinical outcomes in a mixed sample of adult patients with an eating disorder (ED) after receiving Temperament Based Therapy with Support (TBT‐S) at a tertiary eating disorder clinic. Method A naturalistic 12‐month follow‐up study of 46 patients and 65 supports who received the 5‐day TBT‐S treatment was ...
Joakim Skoog, Ingrid Funderud, Kristin Stedal   +2 more
wiley   +1 more source

Nitrous oxide and mood: metabolic mechanisms letter in response to Gill et al. [PDF]

EBioMedicine
Reynolds EH.
europepmc   +1 more source